Robert Bowser, PhD, is Chief Scientific Officer, the John and Betty Van Denburgh Chair of Neuromuscular Disease, and professor and Chair of the Department of Translational Neuroscience at Barrow Neurological Institute. Dr. Bowser is an internationally recognized leader in ALS research, contributing pioneering efforts to discover and validate biomarkers for ALS and other neurodegenerative diseases. These biomarkers have been instrumental as diagnostic biomarkers of disease and predictors of disease progression. They are also used to evaluate the effectiveness of drug treatments in clinical trials. Dr. Bowser is the co-director of a national biorepository of biofluid samples from ALS patients and of a national ALS post-mortem tissue bank. These biofluid and tissue samples linked to clinical information are a critical resource in our search for the cure and used in research efforts throughout the world.